# FDA recall D-0794-2022

> **Teva Pharmaceuticals USA Inc** · Class II · drug recall initiated 2022-04-15.

## Product

Lidocaine 2.5% and Prilocaine 2.5% Cream, USP,  packaged in a) 5 g tubes (NDC 0591-2070-72), b) 30 g tubes (NDC 0591-2070-30), Rx Only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310, USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, USA

## Reason for recall

cGMP Deviations

## Distribution

Nationwide within the United States

## Key facts

- **Recall number:** D-0794-2022
- **Recalling firm:** Teva Pharmaceuticals USA Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-04-15
- **Report date:** 2022-05-04
- **Termination date:** 2023-05-25

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Parsippany, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0794-2022

## Citation

> AI Analytics. FDA recall D-0794-2022. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0794-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*